DUO (DUO) Stock Price & Analysis
DUO (DUO) rose 3.16% to USD 0.91 as of June 10, 2026 at 02:00 UTC, according to Nexqual real-time market data.
DUO last closed at USD 0.88; the session ranged USD 0.71–0.97 on volume of 5,683,833 shares. Market capitalization is $34.96M, with a 52-week range of USD 0.71–5.34 (NCM). Source: Nexqual, June 10, 2026 at 02:00 UTC.
Key Statistics (as of June 10, 2026 at 02:00 UTC)
| Price | USD 0.91 |
|---|---|
| Change | ▲ 3.16% (up) |
| Previous Close | USD 0.88 |
| Open | USD 0.78 |
| Day Range | USD 0.71 – 0.97 |
| 52-Week Range | USD 0.71 – 5.34 |
| Volume | 5,683,833 shares |
| Market Cap | $34.96M |
| Exchange | NCM |
Technical Analysis (DUO)
Nexqual's technical model rates DUO "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 02:00 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 30.83 (neutral) |
| vs SMA50 | Below (USD 1.27) |
| MACD | -0.1 (negative) |
Analyst Ratings (DUO)
Wall Street analysts rate DUO "None", per Nexqual as of June 10, 2026 at 02:00 UTC.
| Consensus Rating | None |
|---|
Earnings (DUO)
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Financials & Fundamentals (DUO)
| Total Revenue | $354.82M |
|---|---|
| Revenue Growth (YoY) | -24.00% |
| Gross Margin | +17.92% |
| Operating Margin | -40.64% |
| Profit Margin | -23.87% |
| ROE | -17.88% |
| Debt / Equity | 0.14 |
| Current Ratio | 1.86 |
| Total Cash | $144.20M |
| Total Debt | $806,000 |
| Free Cash Flow | $-89.63M |
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Financial Health Score (DUO)
Nexqual rates DUO's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 02:00 UTC.
| Growth | Critical — Revenue -62% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 18%, operating -41% |
| Balance Sheet | Strong — $144M cash, no debt |
| Cash Flow | Weak — FCF negative: -$90M, burning cash |
| Efficiency | Critical — ROE -18%, ROA -11.0% |
Ownership (DUO)
| Insider Ownership | +0.31% |
|---|---|
| Institutional Ownership | +0.28% |
| Shares Outstanding | 38.53M |
| Float | 38.41M |
| Short % of Float | +0.29% |
Source: Nexqual, June 10, 2026 at 02:00 UTC.
Leadership (DUO)
DUO is led by Xi Zeng (age 43), Co-Founder, CEO & Chairman, per Nexqual as of June 10, 2026 at 02:00 UTC.
| Co-Founder, CEO & Chairman | Xi Zeng (age 43) |
|---|---|
| COO & Director | Jiaorong Pan (age 45) |
| Director of Capital Markets Department | Linda Li |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KAVL | Kaival Brands Innovations Group | USD 0.05 | ▼ 17% |
| MTC | MMTec, Inc. | USD 2.67 | ▼ 23.71% |
| SXTC | China SXT Pharmaceuticals, Inc. | USD 1.56 | ▲ 8.33% |
| KXIN | Kaixin Holdings | USD 5.24 | ▼ 5.24% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.25 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:00 UTC. This page is informational and not investment advice.